ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 1 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $11,000 | +266.7% | 32,683 | +109.2% | 0.00% | – |
| Q1 2020 | $3,000 | 0.0% | 15,624 | +24.8% | 0.00% | – |
| Q4 2019 | $3,000 | 0.0% | 12,519 | -9.3% | 0.00% | – |
| Q3 2019 | $3,000 | 0.0% | 13,807 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | -57.1% | 13,807 | -6.8% | 0.00% | – |
| Q1 2019 | $7,000 | +16.7% | 14,807 | -0.8% | 0.00% | – |
| Q4 2018 | $6,000 | -50.0% | 14,932 | -14.4% | 0.00% | – |
| Q3 2018 | $12,000 | +20.0% | 17,448 | +6.7% | 0.00% | – |
| Q2 2018 | $10,000 | +66.7% | 16,348 | -1.8% | 0.00% | – |
| Q1 2018 | $6,000 | -62.5% | 16,648 | -33.8% | 0.00% | – |
| Q4 2017 | $16,000 | +6.7% | 25,147 | -3.8% | 0.00% | – |
| Q3 2017 | $15,000 | -53.1% | 26,147 | +0.0% | 0.00% | – |
| Q2 2017 | $32,000 | -60.0% | 26,140 | -50.2% | 0.00% | – |
| Q1 2017 | $80,000 | 0.0% | 52,448 | -42.9% | 0.00% | – |
| Q4 2016 | $80,000 | -32.2% | 91,818 | +4.7% | 0.00% | – |
| Q3 2016 | $118,000 | -13.2% | 87,713 | +14.1% | 0.00% | – |
| Q2 2016 | $136,000 | +16.2% | 76,904 | +31.3% | 0.00% | – |
| Q1 2016 | $117,000 | -38.7% | 58,565 | -1.2% | 0.00% | – |
| Q4 2015 | $191,000 | +151.3% | 59,303 | +38.0% | 0.00% | – |
| Q3 2015 | $76,000 | -61.8% | 42,984 | -42.7% | 0.00% | – |
| Q2 2015 | $199,000 | +57.9% | 74,962 | +46.9% | 0.00% | – |
| Q1 2015 | $126,000 | -49.4% | 51,029 | +20.5% | 0.00% | – |
| Q4 2014 | $249,000 | +492.9% | 42,336 | +571.1% | 0.00% | – |
| Q3 2014 | $42,000 | +133.3% | 6,308 | +150.9% | 0.00% | – |
| Q2 2014 | $18,000 | – | 2,514 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |